Is oral indomethacin effective in treatment of preterm infants with patent ductus arteriosus?

Turkish Journal of Pediatrics

Volumn 46, Issue 2, 2004, Pages 137-141

  Satar, Mehmet ^a   Yapicioǧlu, Hacer ^a   Narli, Nejat ^a   Özbarlas, Nazan ^a   Küçükosmanoǧlu, Osman ^a   Tutak, Ercan ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Oral indomethacin; Patent ductus arteriosus

Indexed keywords

BETAMETHASONE; DIGOXIN; ENDOL; FUROSEMIDE; INDOMETACIN; LUNG SURFACTANT;

ARTICLE; BIRTH WEIGHT; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; GASTROINTESTINAL HEMORRHAGE; GESTATIONAL AGE; HEMODYNAMICS; HUMAN; INFANT; INFANT DISEASE; LUNG DYSPLASIA; MALE; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; PATENT DUCTUS ARTERIOSUS; PREMATURITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL;

ADMINISTRATION, ORAL; CARDIOVASCULAR AGENTS; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFANT, PREMATURE; INFUSIONS, INTRAVENOUS; MALE; TREATMENT OUTCOME;

EID: 2942605844     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bernstein D. Congenital heart disease. In: Behrman ER, Kliegman RM, Jenson HB (eds). Nelson Textbook of Pediatrics (16th ed). Philadelphia: W.B. Saunders Company; 1999. 1362-1413.
2. Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacological closure of patent ductus arteriosus in the premature infant. N Engl J Med 1976; 295: 526-529.
3. Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostoglandin synthesis. N Engl J Med 1976; 295: 530-533.
4. Van Overmeire B, Smets K, Lecoutere D, et al. A comparison of ibuprofen and indomethacin for closure of patent dutus arteriosus. N Engl J Med 2000; 343: 674-681.
5. Van Overmeire B, Van de Broek H, Van Laer P, Weyler J, Vanhaesebrouck P. Early versus late indomethacin treatment for patent ductus artenosus in premature infants with respiratory syndrome. J Pediatr 2001; 138: 205-211.
6. Clymann RI. Patent ductus arteriosus in the premature infant. In: Taeusch HW, Ballard RA (eds). Avery's Diseases of the Newborn (7th ed). Philadelphia: W.B. Saunders Company; 1998: 699-710.
7. Papile LA, Burstein J, Bursteni R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92: 529-534.
8. Walsh MC, Kligman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986; 33: 179-201.
9. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82: 527-532.
10. Greenough A. Chronic lung disease in the newborn. In: Rennie MJ, Roberton NR (eds). Textbook of Neonatology (3rd ed). London: Churchill Livingstone; 1999: 608-630.
11. The Vermont-Oxford Trials Network: very low birth weight outcomes for 1990. Pediatrics 1993; 91: 540-545.
12. Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr 1978; 93: 647-651.
13. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983; 102: 895-906.
14. So LY, Fok TF, Sung RY, Ho JK. Preterm infants with patent ductus arteriosus: treatment with an enteral preparation of indomethacin. Ann Trop Paediatr 1992; 12: 403-408.
15. Shanthala CC, Maiya PP, Vishwanath D, et al. Clinical profile and management of PDA in neonates. Indian J Pediatr 1997; 64: 667-670.
16. Lai TH, Soong WJ, Hwang B. Indomethacin for the prevention of symptomatic patent ductus arteriosus in very low birth weight infants (Abstract). Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1990; 31: 17-23.
17. Betkeru MV, Yeh TF, Miller K, Glasse RJ, Pildes RS. Indomethacin and ist effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. Pediatrics 1981; 68: 99-102.
18. Coombs RC, Morgan ME, Durbin GM, Booth IW, McNeish AS. Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin. Arch Dis Child 1990; 65: 1067-1071.
19. Van Bel F, Van de Bor M, stijnen T, Baan J, Ruys JH. Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect. Pediatrics 1989; 84: 802-807.
20. Van Bel F, Guit GL, Schipper J, Van de Bor M, Baan J. Indomethacin-induced changes, in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging. J Pediatr 1991; 118: 621-626.
21. Maher P, Lane B, Ballard R, Piecuch P, Clyman RI. Does indomethacin cause extension of intracranial hemorrhages: a preliminary study. Pediatrics 1985; 75: 497-500.
22. Ment LR, Oh W, Ehrenkranz RA, et al. Low-dose indomethacin and prevention of intraventricular hemorrhage. A multicenter trial. Pediatrics 1994; 93: 543-550.
23. Davis JM, Hendricks-Munoz KD, Hagberg D, Manning JA. The effects of indomethacin on renal function and intracranial hemorrhage in infants with patent ductus arteriosus. Dev Pharmocol Ther 1990; 14: 15-19.
24. Flanagan MF, Yeager SB, Weindling SN. Cardiac disease. In: Avery GB, Fletcher MA, MacDonald MG (eds). Neonatology Pathophysiology and Management of the Newborn (5th ed). Philadelphia: Lippincott Williams & Wilkins; 1999: 577-646.
25. Weiss H, Cooper B, Brook M, Schleuter M. Clyman R. Factors determining reopening of the ductus arteriosus after successful clinical closures with indomethacin. J Pediatr 1995; 127: 466-471.